These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3155673)

  • 21. Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis.
    James SP; Elson CO; Waggoner JG; Jones EA; Strober W
    J Clin Invest; 1980 Dec; 66(6):1305-10. PubMed ID: 6449520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous mixed-lymphocyte reaction in man. XVII. In vitro effect of ion channel-blocking agents on the autologous mixed-lymphocyte response.
    Gupta S
    Cell Immunol; 1987 Feb; 104(2):290-5. PubMed ID: 2434246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the immune reaction to autologous human lymphoblasts: evidence for the stimulation by activating factors rather than induction by autoantigens.
    Duke-Cohan JS; Hirt R; Dahan A; Naor D
    Clin Immunol Immunopathol; 1987 May; 43(2):229-42. PubMed ID: 2952382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
    Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deficiency of the autologous mixed lymphocyte reaction in patients with autoimmune thyroid disease.
    Canonica GW; Croci R; Bagnasco M; Ferrini S; Cosulich ME; Ferrini O; Giordano G
    Int Arch Allergy Appl Immunol; 1984; 73(2):137-40. PubMed ID: 6229493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome.
    Miyasaka N; Sauvezie B; Pierce DA; Daniels TE; Talal N
    J Clin Invest; 1980 Nov; 66(5):928-33. PubMed ID: 6448867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective autologous mixed lymphocyte reactivity in multiple sclerosis.
    Hirsch RL
    Clin Exp Immunol; 1986 Apr; 64(1):107-13. PubMed ID: 2942317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis.
    Hafler DA; Chofflon M; Kurt-Jones E; Weiner HL
    Clin Immunol Immunopathol; 1991 Jan; 58(1):115-25. PubMed ID: 1670583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous mixed lymphocyte reaction in man. IX. Autologous mixed lymphocyte reaction and lymphocyte subsets in aging humans.
    Gupta S
    Scand J Immunol; 1984 Mar; 19(3):187-91. PubMed ID: 6231715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased autologous mixed lymphocyte reaction in myasthenia gravis.
    Richards I; Harrison R; Lunt GG; Bowen JG
    J Clin Lab Immunol; 1986 May; 20(1):15-21. PubMed ID: 2942690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis.
    Pope RM; McChesney L; Talal N; Fischbach M
    Arthritis Rheum; 1984 Nov; 27(11):1234-44. PubMed ID: 6238599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous proliferation in unfractionated spleen cell cultures: autologous mixed-lymphocyte reactions (AMLR) which can be differentially regulated by prostaglandins and lymphokines.
    Zuberi RI; Katz DH
    Cell Immunol; 1984 Apr; 84(2):299-310. PubMed ID: 6231108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral T-cell lymphoma with unique immunologic features.
    Sheikha A; al-Janadi M; al-Saigh A; Malatani T; Raziuddin S
    Cancer; 1993 Feb; 71(3):831-8. PubMed ID: 8431865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens.
    Amel Kashipaz MR; Huggins ML; Powell RJ; Todd I
    Immunology; 2002 Nov; 107(3):358-65. PubMed ID: 12423312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of a polyclonal B-cell response by supernatants from the murine autologous mixed lymphocyte reaction.
    Wolos JA; Spagnoli B; Smith JB
    Cell Immunol; 1985 Nov; 96(1):61-70. PubMed ID: 2941157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of a cytokine with interleukin 3-like properties and cytokine-dependent proliferation in human autologous mixed lymphocyte reaction.
    Suzuki R; Suzuki S; Takahashi T; Kumagai K
    J Exp Med; 1986 Nov; 164(5):1682-99. PubMed ID: 2430045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation.
    Fuller L; Flaa C; Jaffe D; Strauss J; Kyriakides GK; Miller J
    J Clin Invest; 1983 May; 71(5):1322-30. PubMed ID: 6222068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased autologous mixed lymphocyte reaction with aging.
    Fernandez LA; MacSween JM
    Mech Ageing Dev; 1980 Mar; 12(3):245-8. PubMed ID: 6451776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous mixed lymphocyte reaction in man. XI. Deficiency of autologous mixed lymphocyte reaction and abnormalities of monoclonal antibody-defined T-cell subsets in chronic mucocutaneous candidiasis.
    Gupta S
    Scand J Immunol; 1985 Jun; 21(6):525-30. PubMed ID: 2992070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.